ArticleBMJ open gastroenterology2018

Safety of dual biological therapy in Crohn's disease: a case series of vedolizumab in combination with other biologics.

Eric J Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.